1ISG-015 Multiple sclerosis committee: including a pharmacist as part of the multidisciplinary team

BACKGROUND: Disease modifying therapies (DMT) for multiple sclerosis (MS) have a considerable economic impact on hospitals’ annual budgets. Since February 2017, there has been a shift of power from our Health Service Area to local MS committees to evaluate the appropriateness of DMT prescriptions. P...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Estaun-Martinez, C, Moya-Carmona, I, Pedrosa-Ruiz, M, Mora-Santiago, R, Fernández-Ovies, JM
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 1: Introductory statements and governance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars